StreetInsider.com News Articles

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Wed, 22 Jul 2026 16:01:00 -0400

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Wed, 22 Jul 2026 16:01:00 -0400

Form EFFECT Erste Group Bank AG/ADR

Thu, 09 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260709/26749584.html

Form EFFECT Erste Group Bank AG/ADR

Thu, 09 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260709/26749584.html

Form EFFECT Erste Group Bank AG/ADR

Thu, 09 Jul 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260709/26749584.html

Form 4 Emergent BioSolutions For: Jul 01 Filed by: Williams Paul Anthony

Thu, 02 Jul 2026 12:57:00 -0400

si-local-file:///var/storage/secattach/20260702/26726090.html

Form 4 Emergent BioSolutions For: Jul 01 Filed by: Williams Paul Anthony

Thu, 02 Jul 2026 12:57:00 -0400

si-local-file:///var/storage/secattach/20260702/26726090.html

Form F-6 Erste Group Bank AG/ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary

Wed, 01 Jul 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260701/26722189.html

Form F-6 Erste Group Bank AG/ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary

Wed, 01 Jul 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260701/26722189.html

Form F-6 Erste Group Bank AG/ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary

Wed, 01 Jul 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260701/26722189.html

Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony

Wed, 01 Jul 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260701/26720768.html

Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony

Wed, 01 Jul 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260701/26720768.html

Form 8-K Emergent BioSolutions For: Jun 26

Mon, 29 Jun 2026 11:15:00 -0400

si-local-file:///var/storage/secattach/20260629/26704131.html

Form 8-K Emergent BioSolutions For: Jun 26

Mon, 29 Jun 2026 11:15:00 -0400

si-local-file:///var/storage/secattach/20260629/26704131.html

Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal

Mon, 29 Jun 2026 09:13:29 -0400

Emergent BioSolutions (NYSE: EBS) announced it has received a contract modification valued at $52.7 million from the Administration for Strategic Preparedness and Response, part of the U.S. Department of Health and Human Services, to supply its ACAM2000 smallpox and mpox vaccine.

The contract covers the vaccine itself, ancillary supplies, and diluent replacement lots for smallpox preparedness and response. Deliveries are expected to begin in June 2026. The modification falls under Emergent's existing 10-year contract with ASPR.

The announcement follows recent regulatory approvals for ACAM2000 in other markets. Saudi Arabia's Food and Drug Authority approved the vaccine for immunization against smallpox and mpox

Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal

Mon, 29 Jun 2026 09:13:29 -0400

The announcement follows recent regulatory approvals for ACAM2000 in other markets. Saudi Arabia's Food and Drug Authority approved the vaccine for immunization against smallpox and mpox

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Mon, 29 Jun 2026 09:13:00 -0400

GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human Services to supply ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) vaccine, ancillaries as well as diluent replacement lots for smallpox preparedness and response needs. Deliveries are expected to begin this month.

“This new contract modification for ACAM2000® underscores the U.S. government’s continued focus on biodefense preparedness and reflects Emergent’s longstanding role to collaborate and help

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Mon, 29 Jun 2026 09:13:00 -0400

“This new contract modification for ACAM2000® underscores the U.S. government’s continued focus on biodefense preparedness and reflects Emergent’s longstanding role to collaborate and help

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Mon, 29 Jun 2026 09:13:00 -0400

“This new contract modification for ACAM2000® underscores the U.S. government’s continued focus on biodefense preparedness and reflects Emergent’s longstanding role to collaborate and help

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Mon, 29 Jun 2026 09:13:00 -0400

“This new contract modification for ACAM2000® underscores the U.S. government’s continued focus on biodefense preparedness and reflects Emergent’s longstanding role to collaborate and help

Form 4 Emergent BioSolutions For: Jun 08 Filed by: Williams Paul Anthony

Wed, 10 Jun 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260610/26629503.html

Form 4 Emergent BioSolutions For: Jun 08 Filed by: Williams Paul Anthony

Wed, 10 Jun 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260610/26629503.html

Form 4 Emergent BioSolutions For: Jun 08 Filed by: LINDAHL RICHARD S

Wed, 10 Jun 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260610/26629499.html

Form 4 Emergent BioSolutions For: Jun 08 Filed by: LINDAHL RICHARD S

Wed, 10 Jun 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260610/26629499.html

Form 4 Emergent BioSolutions For: Jun 08 Filed by: Glessner Coleen

Wed, 10 Jun 2026 15:07:00 -0400

si-local-file:///var/storage/secattach/20260610/26629494.html